- Advises the NIH Director and OD program offices on significant legislative activities;
- Serves as the principal NIH legislative liaison with the Congress, the U.S. Department of Health and Human Services, the Office of Management and Budget, other Federal agencies, and non-Federal organizations;
- Prepares the NIH Director and other senior NIH officials to testify at Congressional hearings;
- Analyzes pending legislation to assess likely impact on NIH;
- Monitors and keeps the NIH community informed of key legislative developments that may affect NIH;
- Briefs members of Congress and their staffs on NIH priorities and programs; and
- Coordinates visits to NIH by members of Congress and their staffs.
The Office of Legislative Policy and Analysis (OLPA) within the Office of the Director (OD) is the principle legislative office for the NIH Director and other senior NIH staff. With all authorizing and appropriating authority in the control of Congress, NIH is solely dependent on members of Congress to maintain its programs and activities. OLPA serves as the primary source of leadership and guidance for the NIH Director, NIH senior staff, and the entire NIH community.
OLPA provides essential information, advice, and guidance on Congressional actions affecting NIH to the NIH Director, the Office of the Director, NIH’s Institutes and Centers, and the broader NIH community. OLPA is the principal point-of-contact and liaison with members of Congress and their staff, and performs legislative analysis and policy development in advancing the legislative priorities of the NIH Director and NIH.
NIH is the leading supporter of biomedical research in the world. This research has had a major positive impact on nearly all of our lives by improving human health, fueling the U.S. economy, and creating jobs in our communities.
RePORT provides access to reports, data, and analyses of NIH research activities, including information on NIH expenditures and the results of NIH supported research.